PCM
MED icon

Portolan Capital Management’s Medifast MED Stock Holding History

Portolan Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,606
Closed -$480K – 120
2014
Q3 		$480K Sell
14,606
-46,410
-76% -$1.42M 0.11% 100
2014
Q2 		$1.85M Sell
61,016
-66,956
-52% -$2.09M 0.41% 89
2014
Q1 		$3.72M Sell
127,972
-36,248
-22% -$971K 0.86% 44
2013
Q4 		$4.29M Sell
164,220
-19,692
-11% -$505K 0.95% 38
2013
Q3 		$4.95M Buy
183,912
+94,168
+105% +$2.52M 1.3% 25
2013
Q2 		$2.31M Buy
+89,744
New +$2.36M 0.66% 58

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Portolan Capital Management's MED Position: Q4 2014 in Review

Portolan Capital Management sold out of Medifast (MED) in Q4 2014, closing a stake of 14,606 shares — an estimated $480K sold.

Portolan Capital Management first reported a position in MED in Q2 2013 and held it in 6 quarters. The position peaked at $4.95M in Q3 2013. 124 funds tracked by Wall St. Rank hold MED as of Q4 2014.

  • Portolan Capital Management reported no remaining Medifast position as of Q4 2014 after selling out during the quarter.
  • Portolan Capital Management sold 14,606 Medifast shares in Q4 2014, an estimated $480K.
  • Portolan Capital Management first reported a position in Medifast in Q2 2013 and held it in 6 quarters.
  • Portolan Capital Management's Medifast position peaked at $4.95M in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q4 2014.

Based on Portolan Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.